Loading
A phase 1/2 trial in lung cancer, run by Xemed LLC, not yet recruiting.
Lung Functional Avoidance Radiotherapy Using Hyperpolarized Xenon MRI is a phase 1/2, interventional study registered as NCT07355231 by Xemed LLC, with a registry enrolment figure of 10 participants, started 2027-03-01 and due to reach its primary completion in 2028-02-29. Interventions recorded: Hyperpolarized xenon MRI. Conditions listed: Carcinoma, Non-Small-Cell Lung. Primary outcome: Changes in DLCO at 6-month post RT treatment.. Lung eligibility wording from the registry: "* Patients over 18 years with a diagnosis of non-small lung cancer and planned for a definitive course of radiation therapy". No results are recorded here; the registry entry is the source.
Shares Lung cancer trials open today (registry snapshot), IMRT / IGRT (modern external beam), Non-small-cell lung cancer and the tag lung-deep-dive.
Shares Lung cancer trials open today (registry snapshot), IMRT / IGRT (modern external beam), Non-small-cell lung cancer and the tag lung-deep-dive.
Shares Lung cancer trials open today (registry snapshot), IMRT / IGRT (modern external beam), Non-small-cell lung cancer and the tag lung-deep-dive.
Shares Lung cancer trials open today (registry snapshot), IMRT / IGRT (modern external beam), Non-small-cell lung cancer and the tag lung-deep-dive.
Shares Lung cancer trials open today (registry snapshot), IMRT / IGRT (modern external beam), Non-small-cell lung cancer and the tag lung-deep-dive.
Shares Lung cancer trials open today (registry snapshot), IMRT / IGRT (modern external beam), Non-small-cell lung cancer and the tag lung-deep-dive.
Shares Lung cancer trials open today (registry snapshot), Non-small-cell lung cancer and the tag lung-deep-dive.
Shares Lung cancer trials open today (registry snapshot), Non-small-cell lung cancer and the tag lung-deep-dive.